Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Trapman

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Biochemistry|November 29, 1994
Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sitesG Jenster, P E de Ruiter, H A van der Korput, et al.
Endocrinology|December 6, 1997
Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cellsC B Cleutjens, K Steketee, C C van Eekelen, et al.
Cancer Research|December 5, 2000
Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor geneN Mononen, K Syrjäkoski, M Matikainen, et al.
Molecular and Cellular Endocrinology|February 1, 1989
The N-terminal domain of the human androgen receptor is encoded by one, large exonP W Faber, G G Kuiper, H C van Rooij, et al.
Molecular and Cellular Endocrinology|October 1, 1992
Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell typesL J Blok, A P Themmen, A H Peters, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogensJ Veldscholte, C A Berrevoets, C Ris-Stalpers, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1991
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localizationG Jenster, H A van der Korput, C van Vroonhoven, et al.
Biochemistry|February 4, 1997
Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptorP Doesburg, C W Kuil, C A Berrevoets, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Androgen receptor mutationsA O Brinkmann, G Jenster, C Ris-Stalpers, et al.
Molecular and Cellular Endocrinology|January 1, 1988
Effects of FSH and IGF-I on immature rat Sertoli cells: inhibin alpha- and beta-subunit mRNA levels and inhibin secretionA M Toebosch, D M Robertson, J Trapman, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Biochemistry|November 29, 1994
Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sitesG Jenster, P E de Ruiter, H A van der Korput, et al.
Endocrinology|December 6, 1997
Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cellsC B Cleutjens, K Steketee, C C van Eekelen, et al.
Cancer Research|December 5, 2000
Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor geneN Mononen, K Syrjäkoski, M Matikainen, et al.
Molecular and Cellular Endocrinology|February 1, 1989
The N-terminal domain of the human androgen receptor is encoded by one, large exonP W Faber, G G Kuiper, H C van Rooij, et al.
Molecular and Cellular Endocrinology|October 1, 1992
Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell typesL J Blok, A P Themmen, A H Peters, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogensJ Veldscholte, C A Berrevoets, C Ris-Stalpers, et al.
Molecular Endocrinology (Baltimore, Md.)|October 1, 1991
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localizationG Jenster, H A van der Korput, C van Vroonhoven, et al.
Biochemistry|February 4, 1997
Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptorP Doesburg, C W Kuil, C A Berrevoets, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
Androgen receptor mutationsA O Brinkmann, G Jenster, C Ris-Stalpers, et al.
Molecular and Cellular Endocrinology|January 1, 1988
Effects of FSH and IGF-I on immature rat Sertoli cells: inhibin alpha- and beta-subunit mRNA levels and inhibin secretionA M Toebosch, D M Robertson, J Trapman, et al.
Pageof 14